Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aging: gene silencing or gene activation?

Stanislaw R Burzynski1

  • 1Burzynski Clinic, 9432 Old Katy Road, Houston, TX 77055, USA. info@burzynskiclinic.com

Medical Hypotheses
|November 10, 2004
PubMed
Summary

Aging involves gene silencing, with potential reversal through therapies normalizing gene expression. Age management aims to reactivate silenced genes and control overexpressed oncogenes for healthspan.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete response and long-term survival (>20 years) of a child with tectal glioma: a case report.

Pediatric neurosurgery·2015
Same author

The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2014
Same author

Long-term survival (>13 years) in a child with recurrent diffuse pontine gliosarcoma: a case report.

Journal of pediatric hematology/oncology·2013
Same author

Stanislaw R. Burzynski, MD, PhD: novel cancer research and the fight to prove its worth.

Alternative therapies in health and medicine·2012
Same author

Treatments for astrocytic tumors in children: current and emerging strategies.

Paediatric drugs·2006
Same author

Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma.

Integrative cancer therapies·2006

Area of Science:

  • Genetics and Molecular Biology
  • Gerontology
  • Biochemistry

Background:

  • Aging is characterized by altered gene expression, including the silencing of critical genes like tumor suppressors.
  • Mechanisms of gene silencing involve DNA methylation, histone modification, and RNA interference (RNAi).
  • Genome-wide hypomethylation contributes to genomic instability and oncogene activation.

Purpose of the Study:

  • To explore the role of gene silencing in the aging process.
  • To investigate therapeutic strategies for age management by normalizing gene expression.
  • To identify interventions that can reactivate silenced genes and downregulate overexpressed oncogenes.

Main Methods:

  • Review of existing studies on gene expression changes in aging across various organisms (yeast, worms, flies, mice).
  • Analysis of mechanisms of gene silencing, including DNA methylation, histone modification, and RNAi.
  • Evaluation of the impact of interventions like caloric restriction, exercise, and phytochemicals on gene expression patterns.

Main Results:

  • Aging is associated with silencing of tumor suppressors and genes controlling cell cycle, apoptosis, and metabolism.
  • Increased expression of oncogenes is observed in aging, linked to age-related diseases.
  • Caloric restriction and exercise can normalize expression of many aging-related genes, including tumor suppressors and oncogenes.

Conclusions:

  • Age management therapy should focus on normalizing gene expression to youthful levels.
  • Interventions such as caloric restriction, exercise, phytochemicals, and specific amino acid derivatives show promise in modulating gene expression.
  • Further human studies using DNA microarray techniques are needed to refine age management strategies.

Related Experiment Videos